1
Registered trials
0
Recruiting
1
Unique sponsors
2
Unique IMPs
1
Commercial trials
Drug classes (ATC)
N
Neurology/Psychiatry (ATC N)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Phase II:
1
Phase II
1 trial-
EndedPharmavax AS CommercialEPINEPHRINE, LIDOCAINE HYDROCHLORIDE; PRILOCAINE HYDROCHLORIDE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Pharmavax AS | Commercial | 1 | Phase II | 0 |
New trials by year
2024
1